Tauns Laboratories, Inc. (JP:197A) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TAUNS Laboratories, Inc. has signed a Memorandum of Understanding with Roche Diagnostics K.K. to enter into a Master Transaction Agreement for the sale of TAUNS’ products, aiming to enhance business growth for both companies. The agreement will cover specific diagnostic products and is set to commence in January 2025.
For further insights into JP:197A stock, check out TipRanks’ Stock Analysis page.